Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Moderna

Mentioned in 31 analyzed podcast episodes across 10 shows

This pharmaceutical company is a major mRNA vaccine developer known for producing COVID-19 vaccines approved for children and adults, as well as pursuing mRNA-based flu vaccine candidates. Podcasts frequently discuss Moderna in contexts including FDA regulatory decisions (particularly a recent rejection of its flu vaccine application), government funding for pandemic preparedness, AI applications in drug discovery, and broader debates about vaccine development, clinical trial design, and pharmaceutical industry economics. The company has also faced criticism regarding R&D costs, federal support dependency, and alleged safety monitoring concerns in clinical protocols.

Episode Mentions

Motley Fool Money

Motley Fool Money · Apr 3, 2026

A $2 Trillion IPO & the Space Economy

mRNA technology platform expanding beyond COVID vaccine; stock recovered from $20 lows to $50; diversifying pipeline

Oil Futures Markets and BackwardationStrait of Hormuz Geopolitical RiskSpaceX IPO Valuation and Structure
View Analysis
Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer · Apr 1, 2026

Mad Money w/ Jim Cramer 4/1/26

Vaccine company up 72% in Q1 from FDA approval of flu vaccine and departure of vaccine skeptic from FDA leadership

AI Data Center Infrastructure InvestmentAI Displacement Risk in Enterprise SoftwareMemory and Storage Semiconductor Supply Constraints
View Analysis
Human School

Human School · Apr 1, 2026

Dr. Jeffrey Balser: How Great Leaders Handle Hard Things

Developed COVID-19 vaccine; worked with Vanderbilt researchers on vaccine efficacy testing

Leadership During Crisis ManagementOrganizational Culture and Hiring StrategyEmotional Intelligence and Resilience Training
View Analysis
Digital Disruption with Geoff Nielson

Digital Disruption with Geoff Nielson · Mar 30, 2026

AI is Losing Ground: Futurist Brian Solis on Why AI Adoption is Failing

Moved IT under CHRO, signaling organizational restructuring for AI agent management and HR-IT collaboration

AI Adoption and Maturity ModelsAI Business Reinvention vs. DigitizationWorkflow Reimagination and End-to-End Transformation
View Analysis
Extend Podcast with Darshan Shah, MD

Extend Podcast with Darshan Shah, MD · Mar 12, 2026

146. Dr. Joel Warsh: Vaccines, Ultra-Processed Foods for Kids, Screen Time, and the Modern Parent's Playbook

Developing mRNA flu vaccine with ongoing trial concerns; potential future applications beyond respiratory viruses

Vaccine Schedule Variation and Clinical Decision-MakingPharmaceutical Bias in Medical EducationUltra-Processed Foods and Childhood Chronic Disease
View Analysis
Economist Podcasts

Economist Podcasts · Mar 9, 2026

Follow the leader: Iran picks the son

CEO stated company will reduce clinical trial investments due to waning federal support

Iran supreme leader successionMiddle East infrastructure warfareUS scientific research funding cuts
View Analysis
NPR News Now

NPR News Now · Feb 26, 2026

NPR News: 02-26-2026 5PM EST

Received $1 million donation from Dolly Parton for COVID-19 vaccine research that helped produce vaccine

Congressional Oversight and Committee Rules ViolationsIran Nuclear Negotiations and U.S. Military BuildupTariff Refunds and Trade War Litigation
View Analysis
Breaking Points with Krystal and Saagar

Breaking Points with Krystal and Saagar · Feb 24, 2026

2/24/26: Trump Polling Freefall, Dire Warning On Iran, Lord Mandelson Arrested

Vaccine manufacturer mentioned in context of failed MAHA initiative promises to eliminate vaccines

Trump Approval Rating Decline and Independent Voter CollapsePentagon Munitions Stockpile Depletion and Military ReadinessIran War Risk Assessment and Neoconservative Pressure
View Analysis
DarkHorse Podcast

DarkHorse Podcast · Feb 18, 2026

The History of Vaccine Hesitancy: Jeffrey Tucker on DarkHorse

mRNA vaccine manufacturer whose trials were delayed by Fauci for insufficient racial diversity; benefited from accelerated development timeline

Vaccine Industry Regulatory Capture and History (1776-2024)Intellectual Fragmentation Across Academic DisciplinesCOVID-19 Policy: Lockdowns, Mandates, and Civil Liberties
View Analysis
PBS News Hour - Full Show

PBS News Hour - Full Show · Feb 18, 2026

February 17, 2026 - PBS News Hour full episode

FDA rejected its mRNA flu vaccine application despite late-stage trials showing safety and effectiveness

mRNA Vaccine Development and FDA Approval ProcessChildhood Vaccination Recommendations Policy ChangesTrump Administration Health Policy and Robert F. Kennedy Jr. Influence
View Analysis
Up First from NPR

Up First from NPR · Feb 14, 2026

The Munich Security Conference; FDA Rejects Flu Vaccine; The Fall of The Quad God

FDA rejected its mRNA flu vaccine application aimed at adults 50+, citing insufficient study design despite prior approval of trial methodology

FDA Vaccine Approval Process and Regulatory ConsistencymRNA Vaccine Technology and DevelopmentModerna Flu Vaccine Rejection
View Analysis
Dwarkesh Podcast

Dwarkesh Podcast · Feb 13, 2026

Dario Amodei — The highest-stakes financial model in history

Cited as example of pharmaceutical company that could benefit from AI-accelerated drug discovery

AGI Timeline PredictionsAI Scaling LawsEconomic Diffusion of AI
View Analysis
The DSR Network

The DSR Network · Feb 11, 2026

DSR Daily February 11: Immigration Enforcement Heads Under Fire in House Hearing

FDA issued rare refuse-to-file letter rejecting mRNA flu vaccine application citing outdated clinical trial comparison standards

Immigration Enforcement OversightCongressional Accountability MechanismsFDA Drug Approval Process
View Analysis
The DSR Daily

The DSR Daily · Feb 11, 2026

February 11: Immigration Enforcement Heads Under Fire in House Hearing

FDA issued rare refuse-to-file letter rejecting mRNA flu vaccine application citing inadequate clinical trial design

Immigration Enforcement OversightFederal Agency AccountabilitymRNA Vaccine Policy
View Analysis
The Headlines

The Headlines · Feb 11, 2026

A Deadly Mass Shooting in Canada, and the Latest on the Search for Nancy Guthrie

Drugmaker whose mRNA flu vaccine was rejected for FDA review after years of development and hundreds of millions in testing costs

Mass shooting in Tumbler Ridge, British ColumbiaNancy Guthrie kidnapping investigationTrump administration prosecutions of Democratic lawmakers
View Analysis
This Week in Virology

This Week in Virology · Feb 7, 2026

TWiV 1294: Clinical update with Dr. Daniel Griffin

FDA-approved COVID-19 vaccine for children starting at 6 months of age, recommended by AAP

Measles outbreak response and clinical recognitionPediatric COVID-19 vaccination strategiesLong COVID prevention and treatment
View Analysis
The Shawn Ryan Show

The Shawn Ryan Show · Feb 5, 2026

#277 Michael Lester - Are We the Bad Guys?

Mentioned alongside Pfizer as vaccine manufacturer that profited significantly from pandemic response

U.S. Foreign Policy and Regime Change OperationsMilitary-Industrial Complex and Defense Spending WastePro-Israel Lobbying Influence on Congress
View Analysis
The Dispatch Podcast

The Dispatch Podcast · Jan 30, 2026

Right-Wing Theater Kids

CEO stated company halting new vaccine development due to U.S. market unreliability and inability to recoup R&D costs internationally

Immigration Enforcement Policy and Border Patrol OperationsFederal-Local Law Enforcement Cooperation and Sanctuary CitiesTrump Administration Personnel Management and Loyalty-Based Hiring
View Analysis
Leaked

Leaked · Jan 27, 2026

Redfield on Risk: Gain-of-Function, Bird Flu, and the Next Pandemic

Received $750 million from Biden administration for bird flu vaccine development; criticized as misallocated funding

COVID-19 Lab Origin Theory and Wuhan Institute of VirologyGain-of-Function Research Regulation and EnforcementmRNA Vaccine Safety and Adverse Events
View Analysis
The Joe Rogan Experience

The Joe Rogan Experience · Jan 13, 2026

#2437 - Rand Paul

Mentioned as COVID vaccine manufacturer alongside Pfizer in discussion of pharmaceutical industry influence and government contracts

COVID-19 Pandemic Response and Fauci CriticismNatural Immunity vs. Vaccine MandatesGain-of-Function Research Funding
View Analysis
Leaked

Leaked · Jan 13, 2026

The Lingering Damage: Long Covid, Unanswered Lab Questions, and Accountability Delayed

Vaccine manufacturer with 2014 patent for cancer-mutating gene potentially present in spike protein, discussed in documentary

Long COVID microclot pathology and stem cell growth factor treatmentsVaccine contamination with SV40 and plasmid DNA sequencesCOVID-19 lab leak evidence and Wuhan Institute of Virology research
View Analysis
DarkHorse Podcast

DarkHorse Podcast · Dec 24, 2025

Hey Siri, why are American kids so sick? Aaron Siri on DarkHorse

COVID-19 vaccine manufacturer; clinical trial protocols reviewed for safety monitoring gaps and efficacy calculation methodology

Vaccine Safety Testing Methodology and Placebo ControlsChildhood Vaccine Schedule Expansion and Chronic Disease CorrelationManufacturer Liability Immunity Under 1986 National Childhood Vaccine Injury Act
View Analysis
The Joe Rogan Experience

The Joe Rogan Experience · Dec 17, 2025

#2427 - Bret Weinstein

mRNA vaccine manufacturer; discussed as part of broader mRNA platform rollout and safety concerns

Evolutionary biology and developmental mechanismsVariable number tandem repeats (VNTRs) as genomic information storageAdaptive radiation and explorer modes in evolution
View Analysis
The Tucker Carlson Show

The Tucker Carlson Show · Dec 8, 2025

John Leake: The Demonic Rituals to Replicate God and Mankind’s New Religion of Science

Developed mRNA COVID vaccine with NIH/Fauci's involvement; clinical trials accelerated without long-term safety data

COVID-19 vaccine mandates and coercionmRNA vaccine safety and long-term effectsMyocarditis in adolescents post-vaccination
View Analysis
Me, Myself, and AI

Me, Myself, and AI · Dec 8, 2025

Science, Innovation, and Economic Growth: OpenAI’s Ronnie Chatterji

Referenced as guest on previous podcast episodes discussing AI applications in pharmaceutical R&D

AI-Driven Scientific Innovation and R&D AccelerationGenerative AI Economics and Business ModelsChatGPT Consumer Adoption and Use Cases
View Analysis
The Dylan Gemelli Podcast

The Dylan Gemelli Podcast · Nov 13, 2025

Episode #67 Featuring Aaron Siri !! Author of the book "Vaccines Amen"

COVID-19 vaccine manufacturer; clinical trial data analyzed for safety monitoring duration and placebo controls

Vaccine Clinical Trial Design and Safety Monitoring DurationNational Childhood Vaccine Injury Act of 1986 and Manufacturer Liability ImmunityAluminum Adjuvants and Cellular Toxicity Mechanisms
View Analysis
DarkHorse Podcast

DarkHorse Podcast · Nov 9, 2025

What Paramedics Saw During COVID: Harry Fisher on DarkHorse

mRNA vaccine manufacturer; vaccine insert described as intentionally blank regarding safety data for pregnant women

mRNA vaccine adverse events and myocarditis in pediatric populationsAortic dissection and aneurysm incidence in young adults post-vaccinationInformed consent violations in emergency medicine and public health
View Analysis
The Artificial Intelligence Show

The Artificial Intelligence Show · Oct 30, 2025

#177: AI Answers - AI Ethics, Flagging AI Content, AI Accuracy, Book Recommendations, & AI Intellectual Property

Cited as case study for effective AI integration in learning and development programs

AI Ethics and Responsible AI PrinciplesDeepfakes and Synthetic Media DetectionAI Intellectual Property and Copyright Liability
View Analysis
Building AI Boston

Building AI Boston · Oct 29, 2025

Leading the Life Sciences Revolution with Jenn Azar, CEO of Stellix

Early-stage mRNA company Stellix partnered with to digitize biology and accelerate drug discovery before COVID

AI as organizational strategy vs. technology toolLife sciences manufacturing automation and digitizationmRNA and gene therapy commercialization
View Analysis
The Artificial Intelligence Show

The Artificial Intelligence Show · Oct 23, 2025

#175: AI Answers - AI for 10X Innovation, Rethinking GTM, Dangers of Progress at All Costs, Autonomous Marketing, How to Keep Up with AI, and Future of Web Traffic

AI-first marketing strategyAutonomous marketing capabilitiesAgent-to-agent commerce
View Analysis
Science Vs

Science Vs · May 29, 2025

Dire Wolves! They're Back?

Referenced as size comparison; Colossal's $10B valuation puts it at similar scale to the biotech company

De-extinction technology and genetic engineeringDire wolf resurrection and genetic modificationColossal startup business model and funding
View Analysis